Symptomatic improvement in diabetic neuropathy after 12 months of therapy with zenarestat, an aldose reductase inhibitor

被引：0
|
作者：
Bril, V
Ng, E
Nwe, P
Gogov, S
Ngo, ML
Skandarajah, S
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2136
引用
收藏
页码：A518 / A519
页数：2
相关论文
共 50 条
  • [31] The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat
    Kinoshita, T
    Miyake, H
    Fujii, T
    Takakura, S
    Goto, T
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 622 - 626
  • [32] Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat
    Kuzumoto, Y.
    Kusunoki, S.
    Kato, N.
    Kihara, M.
    Low, P. A.
    DIABETOLOGIA, 2006, 49 (12) : 3085 - 3093
  • [33] DIABETIC GASTROINTESTINAL (GI) NEUROPATHY - EFFECT OF ALDOSE REDUCTASE INHIBITOR (ARI)
    KAVIN, H
    JASPAN, J
    GREEN, A
    GASTROENTEROLOGY, 1986, 90 (05) : 1486 - 1486
  • [34] POLYOL PATHWAY AND DIABETIC NEUROPATHY - SELECTIVE PREVENTIVE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR IN EXPERIMENTAL DIABETIC NEUROPATHY
    KAMIJO, M
    YAGIHASHI, S
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (06) : 629 - 630
  • [35] ABSORPTION, DISTRIBUTION AND EXCRETION OF ZENARESTAT, A NEW ALDOSE REDUCTASE INHIBITOR, IN RATS AND DOGS
    TANAKA, Y
    SEKIGUCHI, M
    SAWAMOTO, T
    KATAMI, Y
    UEDA, T
    ESUMI, Y
    NODA, K
    XENOBIOTICA, 1992, 22 (01) : 57 - 64
  • [36] IMPROVEMENT IN CARDIAC AUTONOMIC NERVE DYSFUNCTION IN DIABETIC-PATIENTS WITH ALDOSE REDUCTASE INHIBITOR THERAPY
    JASPAN, J
    HEROLD, K
    BARTKUS, C
    CLINICAL RESEARCH, 1985, 33 (02): : A433 - A433
  • [37] Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients
    Baba, M
    Kimura, K
    Suda, T
    Yagihashi, S
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2006, 11 (02) : 176 - 178
  • [38] Cardiac abnormalities in diabetic patients with neuropathy - Effects of aldose reductase inhibitor administration
    Johnson, BF
    Nesto, RW
    Pfeifer, MA
    Slater, WR
    Vinik, AI
    Chyun, DA
    Law, G
    Wackers, FJT
    Young, LH
    DIABETES CARE, 2004, 27 (02) : 448 - 454
  • [39] EFFECT OF A NEW POTENT ALDOSE REDUCTASE INHIBITOR, TAT ON DIABETIC NEUROPATHY OF RATS
    HOTTA, N
    KAKUTA, H
    KOH, N
    SAKAKIBARA, F
    KOMORI, H
    INUKAI, S
    NAITO, S
    SAKAMOTO, N
    DIABETOLOGIA, 1992, 35 : A151 - A151
  • [40] ONE-YEAR TREATMENT WITH THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT, IN DIABETIC NEUROPATHY
    ZIEGLER, D
    MAYER, P
    RATHMANN, W
    GRIES, FA
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 14 (01) : 63 - 74
12345